Skip to main content
Dawn Davis, MD, Endocrinology, Madison, WI

DawnBeltDavisMDPhD(She/Her)

Endocrinology • Madison, WI

Diabetes, Lipid Metabolism, Obesity

Professor, University of Wisconsin-Madison Department of Medicine, Division of Endocrinology, Diabetes and Metabolism

Join to view full profile

Dr. Davis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Davis' full profile

Already have an account?

  • Office

    University Of Wisconsin Hospital And Clinics
    4142 MFCB, MC5148, 1685 Highland Ave
    Madison, WI 53705
    Phone+1 608-263-5010

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Endocrinology, Diabetes, and Metabolism, 2008
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 2005
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
  • University of Chicago
    University of ChicagoPhD, Pathology, 1995 - 2001

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2005 - 2025
  • WA State Medical License
    WA State Medical License 2003 - 2005
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Senior Clinician Scientist Investigator Award Department of Veterans Affairs
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Laparoscopic reversal of Roux-en-Y gastric bypass: technique and utility for treatment of endocrine complications  
    Campos GM, Ziemelis M, Paparodis R, Ahmed M, Davis DB, Surg Obes Relat Dis, 1/2014

Lectures

  • Tcf19 Is a Key Transcriptional Regulator of ER Stress in the Beta Cell 
    Madison, WI - 6/15/2014
  • FoxM1 Overexpression in Beta-Cells Lowers Plasma Glucose and Increases Pancreatic Insulin Content 
    Madison, WI - 6/16/2014

Press Mentions

  • Childhood Type 2 Diabetes up 200% in State
    Childhood Type 2 Diabetes up 200% in StateApril 16th, 2022
  • Approaching a Cure: Treatments Offer Promise to Delay, Improve Life with Type 1 Diabetes
    Approaching a Cure: Treatments Offer Promise to Delay, Improve Life with Type 1 DiabetesFebruary 22nd, 2022
  • Studies Continue to Show A Link Between Obesity and Severe COVID-19 Illness
    Studies Continue to Show A Link Between Obesity and Severe COVID-19 IllnessMarch 15th, 2021
  • Join now to see all

Grant Support

  • The impact of cholecystokinin on pancreatic beta-cell survival through paracrine and pharmacologic signalingDepartment of Veterans Affairs2024–Present
  • Functional studies of the novel diabetes gene TCF19Department of Veterans Affairs Merit Review Award2019–2023
  • The role of GLP-1 and CCK in the pancreatic islet to promote beta-cell survivalNational Institute of Diabetes and Digestive and Kidney Diseases2016–2022
  • Tranascriptional regulation of pancreatic beta cell massVeterans Affairs Merit Review Award2013–2017
  • Mechanisms Of Beta Cell Proliferation In Mouse And Human IsletsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011

Committees

  • Diabetes Team Lead, Endocrine Society Annual Meeting Steering Committee 2018 - Present

Professional Memberships

Dr. Dawn Davis, Dr. Dawn Davis, MD, Dr. D Davis, Dr. Dawn Belt Davis